Benign Prostatic Hyperplasia

Urology

Non-malignant prostate enlargement causing LUTS in older men.

History taking

  • IPSS — voiding (hesitancy, weak stream, incomplete emptying) and storage (frequency, urgency, nocturia)

Examination

  • DRE: smooth, firm, enlarged

Red flags

  • Haemodynamic instability
  • Rapid deterioration
  • Severe pain or new neurological deficit

Differential diagnosis

  • See differentials section per chief complaint

Recommended investigations

  • Urinalysis, PSA (counsel), U&E
  • USS post-void residual, uroflowmetry

Diagnosis

  • Clinical diagnosis supported by targeted investigations

Initial treatment / management

  • Treat underlying cause
  • Symptomatic relief
  • Patient education

Drug therapy

  • Tamsulosin 400 µg OD (α-blocker)
  • Add finasteride / dutasteride if large prostate >30 g
  • Tadalafil 5 mg OD if concurrent ED

Follow-up advice

  • Review in 2–4 weeks or earlier if worsening
  • Monitor response to therapy and adverse effects

Patient counselling

  • Explain diagnosis and natural course in lay terms
  • Red-flag symptoms warranting urgent return
  • Adherence to medications and follow-up

Referral criteria

  • Urology for refractory symptoms, retention, haematuria, raised PSA

References

  • Harrison's Principles of Internal Medicine, 21e
  • NICE / WHO guidelines (current edition)

Educational outpatient guide — verify against local guidelines before clinical use.

WardRound

WardRound

Clinical Decisions in Seconds